Skip to main content

and
  1. No Access

    Article

    Allogeneic stem cell transplantation for the treatment of advanced solid tumors

    Allogeneic stem cell transplantation has emerged as a potentially curative treatment modality for patients with hematological malignancies. The graft-versus-leukemia effect, an immune mechanism mediated by the...

    Marco Bregni, Massimo Bernardi, Fabio Ciceri in Springer Seminars in Immunopathology (2004)

  2. No Access

    Article

    Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients

    Febrile neutropenia and sepsis are common and life-threatening complications in hematological diseases. This study was performed retrospectively in 514 patients treated for febrile neutropenia at our institute...

    Raffaella Greco, Maria Chiara Barbanti, Nicasio Mancini in Bone Marrow Transplantation (2018)

  3. No Access

    Article

    Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP

    Raffaella Greco, Fabio Ciceri, Maddalena Noviello in Bone Marrow Transplantation (2018)

  4. Article

    Open Access

    Ultrasound elastography techniques for diagnosis and follow-up of hepatic veno-occlusive disease

    Lorenzo Lazzari, Paolo Marra, Raffaella Greco, Fabio Giglio in Bone Marrow Transplantation (2019)

  5. Article

    COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome

    Maria Teresa Lupo-Stanghellini, Elisabetta Xue in Bone Marrow Transplantation (2021)

  6. No Access

    Article

    Coadministration of letermovir and sirolimus in allogeneic hematopoietic cell transplant recipients

    Elisabetta Xue, Francesca Lorentino, Daniela Clerici in Bone Marrow Transplantation (2022)

  7. No Access

    Article

    Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience

    Simona Piemontese, Lorenzo Lazzari, Annalisa Ruggeri in Bone Marrow Transplantation (2022)

  8. Article

    Open Access

    Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01

    The outcome of refractory/relapsed (R/R) acute leukemias is still dismal and their treatment represents an unmet clinical need. However, allogeneic transplantation (allo-HSCT) remains the only potentially cura...

    Francesca Bonifazi, Chiara Pavoni, Jacopo Peccatori in Bone Marrow Transplantation (2022)

  9. Article

    Open Access

    Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia

    Post-transplant cyclophosphamide (PTCy) has emerged as a promising graft-versus-host disease (GvHD) prophylaxis in allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, no studies have repor...

    Lorenzo Lazzari, Aitana Balaguer-Roselló, Juan Montoro in Bone Marrow Transplantation (2022)

  10. Article

    Open Access

    A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease

    X-linked chronic granulomatous disease is a rare disease caused by mutations in the CYBB gene. While more extensive knowledge is available on genetics, pathogenesis, and possible therapeutic options, mitochond...

    Maddalena Migliavacca, Luca Basso Ricci, Giada Farinelli in Journal of Clinical Immunology (2022)

  11. Article

    Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party

    Raffaella Greco, Jorinde D. Hoogenboom in Bone Marrow Transplantation (2023)

  12. No Access

    Article

    Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir

    Cytomegalovirus (CMV) reactivations are strong stimulators of immune-reconstitution (IR) in hematopoietic stem cell transplantation (HSCT) recipients. Herein, we analyzed 317 CMV-seropositive consecutive patie...

    Giorgio Orofino, Elisabetta Xue, Matteo Doglio in Bone Marrow Transplantation (2023)

  13. No Access

    Article

    Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients

    Simona Piemontese, Maria Teresa Lupo Stanghellini in Bone Marrow Transplantation (2024)